Evidence map›Paper›PMID 26773531›Full record

ArticleJournal of cellular and molecular medicine2016

Replication study of 34 common SNPs associated with prostate cancer in the Romanian population.

Viorel Jinga, Irma Eva Csiki, Andrei Manolescu, Paul Iordache, Ioan Nicolae Mates, Daniel Radavoi, Stefan Rascu, Daniel Badescu, Paula Badea, Dana Mates

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Association of selectedPathology oncology research : POR · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Viorel Jinga"Prof. Dr. Th. Burghele" Clinical Hospital, Urology Department, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Irma Eva CsikiNational Institute of Public Health, Bucharest, Romania.
Andrei ManolescuSchool of Science and Engineering, Reykjavik University, Reykjavik, Iceland.
Paul IordacheSchool of Science and Engineering, Reykjavik University, Reykjavik, Iceland.
Ioan Nicolae Mates"St Mary" Clinical Hospital, General Surgery Department, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Daniel Radavoi"Prof. Dr. Th. Burghele" Clinical Hospital, Urology Department, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Stefan Rascu"Prof. Dr. Th. Burghele" Clinical Hospital, Urology Department, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Daniel Badescu"Prof. Dr. Th. Burghele" Clinical Hospital, Urology Department, University of Medicine and Pharmacy "Carol Davila", Bucharest, Romania.
Paula BadeaNational Institute of Public Health, Bucharest, Romania.
Dana MatesNational Institute of Public Health, Bucharest, Romania.
Carol Davila University of Medicine and Pharmacy · RONational School of Public Health, Management and Professional Development · ROReykjavík University · IS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer is the third-most common form of cancer in men in Romania. The Romanian unscreened population represents a good sample to study common genetic risk variants. However, a comprehensive analysis has not been conducted yet. Here, we report our replication efforts in a Romanian population of 979 cases and 1027 controls, for potential association of 34 literature-reported single nucleotide polymorphisms (SNPs) with prostate cancer. We also examined whether any SNP was differentially associated with tumour grade or stage at diagnosis, with disease aggressiveness, and with the levels of PSA (prostate specific antigen). In the allelic analysis, we replicated the previously reported risk for 19 loci on 4q24, 6q25.3, 7p15.2, 8q24.21, 10q11.23, 10q26.13, 11p15.5, 11q13.2, 11q13.3. Statistically significant associations were replicated for other six SNPs only with a particular disease phenotype: low-grade tumour and low PSA levels (rs1512268), high PSA levels (rs401681 and rs11649743), less aggressive cancers (rs1465618, rs721048, rs17021918). The strongest association of our tested SNP's with PSA in controls was for rs2735839, with 29% increase for each copy of the major allele G, consistent with previous results. Our results suggest that rs4962416, previously associated only with prostate cancer, is also associated with PSA levels, with 12% increase for each copy of the minor allele C. The study enabled the replication of the effect for the majority of previously reported genetic variants in a set of clinically relevant prostate cancers. This is the first replication study on these loci, known to associate with prostate cancer, in a Romanian population.

Indexed as

Genetic LociGenetic Predisposition to DiseasePolymorphism, Single NucleotideAllelesCase-Control StudiesGenome, HumanGenome-Wide Association StudyHumansMaleNeoplasm GradingNeoplasm StagingProstate-Specific AntigenProstatic NeoplasmsRisk FactorsRomaniaProstate-Specific Antigenprostate cancerreplicationsingle nucleotide polymorphisms

Identifiers

PMID26773531
PMCPMC5126261
OpenAlexW2237800581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.